0001209191-18-050575.txt : 20180911 0001209191-18-050575.hdr.sgml : 20180911 20180911194006 ACCESSION NUMBER: 0001209191-18-050575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180910 FILED AS OF DATE: 20180911 DATE AS OF CHANGE: 20180911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pla Frederic CENTRAL INDEX KEY: 0001649167 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 181065812 MAIL ADDRESS: STREET 1: C/O GENOMIC HEALTH, INC. STREET 2: 101 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063-4700 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-10 0 0001131324 GENOMIC HEALTH INC GHDX 0001649167 Pla Frederic 301 PENOBSCOT DR. REDWOOD CITY CA 94063 0 1 0 0 Chief Bus & Prod Dev Officer Common Stock 2018-09-10 4 M 0 1500 27.00 A 37038 D Common Stock 2018-09-10 4 S 0 1100 62.6818 D 35938 D Common Stock 2018-09-10 4 S 0 400 63.7925 D 35538 D Employee Stock Option (right to buy) Holding 27.00 2018-09-10 4 M 0 1500 0.00 D 2026-02-16 Common Stock 1500 58700 D Includes an aggregate of 18,734 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 7, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $62.46 to $63.08. Represents weighted average sale price. Actual sale prices ranged from $63.47 to $63.92. The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2018-09-11